Fingerprint
Dive into the research topics of 'Rationale and design of MARQUEE: A phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically